Literature DB >> 19960965

Reversible focal splenium lesion--MRS study of a different etiology.

Yu-Wei Lin1, Chin-Yin Yu.   

Abstract

A 36-year-old man with staphylococcal meningitis had similar symptoms and MRI characteristics as reversible splenium lesion syndrome described in the literature-hyperdensity on DWI and T2WI/FLAIR, hypodensity on ADC, iso-intensity on T1WI, and no contrast enhancement on midline splenium. The splenium lesion on MRI disappeared as the symptoms improved. The etiology of staphylococcal meningitis was different from other reported cases, and the MRS study showed relatively elevated lactate and myo-inositol of splenium as compared to other selective regions in the brain (both white matter and gray matter), which implies increased anaerobic glycolysis and hyperosmolar state on the splenium. The ratios of NAA/Cr, NAA/Cho, and Cho/Cr were abnormal in all selected regions, indicating that the pathologic change involved the whole brain. More series MRS and other advanced exams to correlate intracranial environment (ex. cerebral blood flow, osmolality, inflammatory process, metabolites distribution, and neurotransmitter changes) are needed to confirm the mechanisms of different etiologies with reversible splenium lesion syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19960965

Source DB:  PubMed          Journal:  Acta Neurol Taiwan        ISSN: 1028-768X


  2 in total

1.  Brain MRI of children with retinopathy-negative cerebral malaria.

Authors:  Douglas G Postels; Chenxi Li; Gretchen L Birbeck; Terrie E Taylor; Karl B Seydel; Sam D Kampondeni; Simon J Glover; Michael J Potchen
Journal:  Am J Trop Med Hyg       Date:  2014-09-08       Impact factor: 2.345

2.  Statistical Analysis of the Apparent Diffusion Coefficient in Patients with Clinically Mild Encephalitis/Encephalopathy with a Reversible Splenial Lesion Indicates That the Pathology Extends Well beyond the Visible Lesions.

Authors:  Yang Qing; Wang Xiong; Huang Da-Xiang; Zhu Juan; Wang Fei; Yu Yong-Qiang
Journal:  Magn Reson Med Sci       Date:  2019-04-05       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.